Mechanisms of action of extracorporeal photopheresis in the control of bronchiolitis obliterans syndrome (BOS): involvement of circulating miRNAs
S Bozzini, C Del Fante, M Morosini, HO Berezhinskiy… - Cells, 2022 - mdpi.com
Clinical evidence suggests an improvement or stabilization of lung function in a fraction of
patients with bronchiolitis obliterans syndrome (BOS) treated by extracorporeal …
patients with bronchiolitis obliterans syndrome (BOS) treated by extracorporeal …
[HTML][HTML] Collection efficiency of mononuclear cells in offline extracorporeal photopheresis: can processing time be shortened?
O Kartal, N Lindlbauer, S Laner-Plamberger… - Blood …, 2024 - ncbi.nlm.nih.gov
Background Extracorporeal photopheresis (ECP) is a well-established but lengthy and
burdensome cell-based therapy for various diseases such as cutaneous T-cell lymphoma …
burdensome cell-based therapy for various diseases such as cutaneous T-cell lymphoma …
Increasing the collection flow rate to 2 mL/min is effective and reduces the procedure time in off‐line photopheresis
W Mayer, J Mayr, F Koch, U Rechberger… - …, 2023 - Wiley Online Library
Background Extracorporeal photopheresis (ECP) treatment, mostly based on apheresis
technology, is used for immunomodulation in various diseases such as cutaneous T‐cell …
technology, is used for immunomodulation in various diseases such as cutaneous T‐cell …